Nine months after raiding the offices of Sanofi in an unannounced inspection, the European Commission says it has started formal proceedings in an antitrust investigation against the French drugmaker.
The probe surrounds Sanofi’s marketing of its flu vaccine for at-risk seniors, Efluelda, and…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.